We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

81 hedge funds and large institutions have $501M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

38% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 13

21% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 38

20% more capital invested

Capital invested by funds: $418M → $501M (+$83M)

11% more funds holding

Funds holding: 73 → 81 (+8)

17% less call options, than puts

Call options by funds: $2.35M | Put options by funds: $2.83M

Holders
81
Holders Change
+8
Holders Change %
+10.96%
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
46
Increased
18
Reduced
13
Closed
38
Calls
$2.35M
Puts
$2.83M
Net Calls
-$476K
Net Calls Change
-$7.87M

Top Buyers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
+$50.4M
2
SAM
Sandell Asset Management
New York
+$41.5M
3
OP
Omni Partners
United Kingdom
+$41.1M
4
JP Morgan Chase
JP Morgan Chase
New York
+$27.2M
5
OAM
Oxford Asset Management
United Kingdom
+$21.7M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$154M
2
MMH
Menora Mivtachim Holdings
Israel
-$24.2M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$23.2M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$21.2M
5
Franklin Resources
Franklin Resources
California
-$19M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
26
Wolverine Asset Management
Illinois
$4.36M +$4.13M +112,208 New
Renaissance Technologies
27
Renaissance Technologies
New York
$4.14M +$3.92M +106,500 New
GKIM
28
GW&K Investment Management
Massachusetts
$3.78M -$25K -680 -0.7%
UBS Group
29
UBS Group
Switzerland
$3.75M +$3.46M +94,102 +4,004%
PCM
30
Prelude Capital Management
New York
$3.56M +$3.33M +90,657 +10,349%
SMC
31
S. Muoio & Co
New York
$3.42M +$3.24M +87,950 New
State Street
32
State Street
Massachusetts
$3.02M +$706K +19,200 +33%
RG
33
Redmile Group
California
$2.98M -$17.6M -478,367 -86%
CI
34
Cowen Inc
New York
$2.86M +$2.35M +64,000 New
OM
35
Opaleye Management
Massachusetts
$2.72M -$1.85M -50,300 -42%
Deutsche Bank
36
Deutsche Bank
Germany
$2.62M +$2.13M +57,799 +608%
KC
37
Kellner Capital
New York
$2.55M +$2.41M +65,600 New
KAM
38
Kassirer Asset Management
Ontario, Canada
$2.33M +$2.21M +59,989 New
Vanguard Group
39
Vanguard Group
Pennsylvania
$2.14M +$1.77M +48,000 +684%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$1.95M +$1.85M +50,160 New
PAMP
41
Polar Asset Management Partners
Ontario, Canada
$1.95M +$1.84M +50,000 New
Northern Trust
42
Northern Trust
Illinois
$1.91M -$304K -8,277 -14%
HA
43
Havens Advisors
New York
$1.78M +$1.68M +45,750 New
GI
44
GAMCO Investors
Connecticut
$1.51M +$1.43M +38,810 New
DCM
45
DAFNA Capital Management
California
$1.48M – – –
MTCM
46
Mint Tower Capital Management
Netherlands
$1.43M +$1.35M +36,783 New
SG Americas Securities
47
SG Americas Securities
New York
$1.34M +$1.26M +34,367 New
DCM
48
Dupont Capital Management
Delaware
$1.32M +$1.25M +33,900 New
VOAM
49
Vertex One Asset Management
British Columbia, Canada
$1.14M +$1.07M +29,200 New
SEC
50
Seven Eight Capital
New York
$1.12M +$1.06M +28,700 New
1
2
3 4 5

NDRM Hedge Fund Activity: Q3 2017 in Review

81 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q3 2017, worth a combined $501M — up 20% from $418M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new NDRM positions and 38 closed out — a net gain of 8 holders — while 18 added to existing stakes and 13 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $50.4M. The largest seller was Scopia Capital Management, cutting an estimated $154M.

  • 81 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q3 2017, up from 73 in Q2 2017.
  • Funds reported $501M of NeuroDerm Ltd. Ordinary Shares stock for Q3 2017, up 20% quarter-over-quarter.
  • 46 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q3 2017 and 38 closed out, a net change of +8 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q3 2017 was AQR Arbitrage, an estimated $50.4M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q3 2017 was Scopia Capital Management, an estimated $154M sold.

Based on aggregated 13F filings for Q3 2017.